Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Introduction: Chronic idiopathic constipation (CIC) is a prevalent functional gastrointestinal disorder diagnosed based on patient-reported symptoms and the absence of structural gastrointestinal abnormalities. Individuals with CIC typically institute dietary changes and use stool softeners or over-the-counter (OTC) laxatives, possibly at the direction of a healthcare provider, before prescription medications for CIC are initiated. Although highly prevalent, there is limited information regarding CIC patient experiences with OTC medications. Methods: This post-hoc analysis used patient-reported data from a questionnaire administered during patient screening for a prospective linaclotide Phase 3b clinical trial in patients with CIC (N = 1482 screened). The questionnaire asked patients to report their experiences with OTC CIC medications over the preceding 6 months. Results: Among patients with screening responses (N = 1423), most were female (85%) and white (66%), with a mean age of 48.9 years. A high proportion of patients had used one or more OTC medications (70% had ≥1 OTC; 19% had ≥3 OTCs), with the majority being bisacodyl (33%) and polyethylene glycol (30%). The most commonly cited reason for stopping an OTC medication was insufficient symptom relief (17–40%). The majority of patients taking OTC medications reported no or little satisfaction with the medication’s effect on their constipation (62%) and CIC-specific abdominal symptoms (78%). Many patients had little to no confidence in bowel movement (BM) frequency after taking OTC medications and their confidence in their ability to predict BM timing was also low (49–81% not at all confident). Conclusions: Treatment effects on individual CIC symptoms, predictability of bowel habits, and satisfaction with treatment are all important factors for healthcare providers and patients to consider when establishing an effective treatment regimen for CIC. Trial registration number: NCT01642914
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The use of linaclotide leads to increases in the number of CSBMs per week (MD 1.37, 95% CI 1.07-1.95) and SBMs per week (MD 1.97, 95% CI 1.59-2.36), improves stool consistency (MD 1.25, 95% CI 1.1-1.39 higher), and increases the rates of global relief (RR 1.96, 95% CI 1.63-2.35).”
From American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation (2023) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Self-citationFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Epidemiology of Constipation in North America: A Systematic Review
Higgins, P. D., & Johanson, J. F. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04114.x · Cited by 1,080
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 645
Self-citationChronic constipation: a survey of the patient perspective
JOHANSON, J. F., & KRALSTEIN, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03238.x · Cited by 617
Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire
Marquis, P., De La Loge, C., Dubois, D., McDermott, A., & Chassany, O. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510012208 · Cited by 584
American Gastroenterological Association Medical Position Statement on Constipation
Bharucha, A. E., Dorn, S. D., Lembo, A., & Pressman, A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.029 · Cited by 521
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation
Kamm, M. A., Mueller–Lissner, S., Wald, A., Richter, E., Swallow, R., & Gessner, U. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.026 · Cited by 257
Functional bowel disorders and functional abdominal pain
Thompson, W., Irvine, E., Drossman, D., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/x3mq-ct28 · Cited by 204
Heidelbaugh, J. J., Stelwagon, M., Miller, S. A., Shea, E. P., & Chey, W. D. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.67 · Cited by 157
Self-citation
Research works printed but not linked: 2
- JC Eoff, 2008, Optimal treatment of chronic constipation in managed care: review and roundtable discussion, J Manag Care Pharm, 14, 1
- DA Drossman, 1999, Rome II: a multinational consensus document on functional gastrointestinal disorders
Cited by
Chang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S., Greer, K. B., Hanson, B., Harris, L. A., Ko, C., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.214 · Cited by 185
Smart pills for gastrointestinal diagnostics and therapy
Cummins, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113931 · Cited by 81
Chang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S. J., Greer, K. B., Hanson, B., Harris, L. A., Ko, C. W., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002227 · Cited by 56
“Three 12-week randomized doubleblinded placebo-controlled trials evaluated the use of linaclotide for the management of CIC (10,64).”
Van Der Schoot, A., Katsirma, Z., Whelan, K., & Dimidi, E. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17782 · Cited by 38
Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge
Whorwell, P. J., Lange, R., & Scarpignato, C. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241249664 · Cited by 28
“This hypothesis is corroborated by another study by Lacy et al. , 96 who found that compared with stimulant laxatives (bisacodyl, SPS, senna), other non-stimulant laxatives (PEG, stool softeners, bulk laxatives, and wheat dextrin) provided a lower degree of satisfaction with the medication’s effect…”
Result
Metadata
- Authors
- Lacy, B. E., Shea, E. P., Manuel, M., Abel, J. L., Jiang, H., & Taylor, D. C. A.
- Affiliations
- Mayo Clinic in Florida (US)
- Ironwood Pharmaceuticals (United States) (US)
- AbbVie (United States) (US)
- Corresponding author
- Lacy, Brian E.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-01-11
- Volume
- 16
- Issue
- 1
- Pages
- e0243318
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7799845
- OpenAlex
- W3119891294
- Cited by
- 17
- References
- 24
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 1
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Allergan plc
- Ironwood Pharmaceuticals, Inc.
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- chronic idiopathic constipation, over-the-counter laxatives, patient experience, bisacodyl, polyethylene glycol, stool softeners, treatment satisfaction, linaclotide, functional gastrointestinal disorders
- MeSH terms
- Adolescent, Adult, Aged, Chronic Disease, Constipation, Nonprescription Drugs, Female, Humans, Male, Middle Aged, Peptides, Surveys and Questionnaires, Time Factors, Patient Satisfaction, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. https://app.cochat.ai/papers/10.1371/journal.pone.0243318
- The paper
- Lacy, B. E., Shea, E. P., Manuel, M., Abel, J. L., Jiang, H., & Taylor, D. C. A. (2021). Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. PLOS ONE. https://doi.org/10.1371/journal.pone.0243318
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.